Mar 25, 2019 7:00am EDT XORTX Shares Findings of New Diabetes Study Supporting Uric Acid as an Independent Risk Factor
Mar 12, 2019 10:51am EDT XORTX Signs LOI for Co-Development and Licensing Agreement with Japan’s Teijin Pharma Limited
Jan 28, 2019 7:00am EST XORTX to Present at NobleConXV Noble Capital Markets’ 15th Annual Investor Conference
Oct 23, 2018 7:00am EDT XORTX Announces Revision to Polycystic Kidney Disease Clinical Development Plan